1.MRI characteristics and pathological comparison of cesarean scar pregnancy during the first-trimester
Xiaojie CHENG ; Li CHEN ; Li XIAO ; Ruoqin CHENG ; Diyu LU
Journal of Practical Radiology 2015;(1):102-105
Objective To study the MRI findings and pathologic characteristics of cesarean scar pregnancy during the first-trimes-ter.Methods Clinical data,MRI findings and pathologic manifestations of 23 CSP patients confirmed by surgery and pathology were analyzed retrospectively.Results On pathologic specimens by the microscope,villi and decidua tissue were found in the myometrium of all 23 cases (100%),and smooth muscle tissue in the uterus scar was incomplete in 12 cases (52.2%).The incision scars were found in the uterine lower antetheca in 21 cases,which showed low signal on T1 WI and T2 WI.A majority of the gestational sac pro-truded into intrauterine in 12 cases.The gestational sac located in the scar of lower uterine antetheca in 10 cases and in the myometri-um around the scar in 1 case.The gestational sac of 22 cases were quasi-round with the size between 1.8 cm×1.2 cm and 6.4 cm× 2.7 cm.The gestational sacs showed homogeneous low signal on T1 WI and high signal on T2 WI in 8 cases,heterogeneous high signal on T2 WI and STIR sequence in 1 5 cases,a little short T1 signal of bleeding in 9 cases,and heterogeneous high signal on DWI sequence in 3 cases.The gestational sac borders were well-defined in 18 cases and blurred in 5 cases.Among 5 cases performed by enhanced MRI,there were 3 cases which gestational sac walls were ring-shaped enhanced.Conclusion MRI findings of CSP had certain char-acteristics and could reflect the pathological characteristics of CSP.MRI had important reference value in early diagnosis of CSP and the choice of treatment.
2.Analysis of risk factor of bile duct injury during laparoscopic cholecystectomy
Xiujun CAI ; Jida CHEN ; Zhenxu ZHOU ; Xianfa WANG ; Hong YU ; Xiao LIANG ; Diyu HUANG ; Xueyong ZHENG
Chinese Journal of General Surgery 1997;0(06):-
Objective To analyze risk factor of bile duct injury (BDI) during laparoscopic cholecystectomy (LC). Methods A retrospective population-based cohort study was carried out on 13878 patients undergoing LC from Apr 1994 to Dec 2003. Patients were divided into BDI group and non-BDI group. Factors with statistically significant differences between groups in anivariable analysis were selected to construct a multivariate logistic regression mode. Result Among 13878 LC procedures 38 BDI (0.27%) were identified. Factors which were of significant differences between groups in anivariable analysis includ diameter of common bile duct(?~2=5.92, P
3.Laparoscopic hepatectomy:a report of 20 cases
Xiujun CAI ; Jida CHEN ; Xiao LIANG ; Diyu HUANG ; Hong YU ; Xianfa WANG ; Hai HUANG ; Libo LI ; Shengdong WU ; Shuyou PENG
Chinese Journal of General Surgery 1993;0(02):-
Objective To evaluate the maneuvre of curettage and aspiration(LTCA) in laparoscopic hepatectomy. MethodsWe used Peng′s multifunctional operative dissector(PMOD) to perform laparoscopic liver transection by maneuvre of curettage and aspiration in 20 cases undergoing laparoscopic hepatectomy. Results Procedures were all successful. The recovery was uneventful without any complications. Mean operative time was 105 minutes, the average bleeding volume was 420 ml, the largest excised sample size was 10 cm?9 cm?7 cm. All patients were discharged within one week. ConclusionsThe new technique-LTCA can be used in laparoscopic hepatectomy, it has the advantages of clear anatomy, good exposure of canal construction, rapid liver transection, satisfactory hemostasis and clear operative field.
4.Research progress of iron metabolism in phenotype modification of β-thalassemia.
Chinese Journal of Medical Genetics 2021;38(1):27-31
β-thalassemia is a type of inherited hemolytic anemia caused by decreased globin production due to defect of the HBB gene. The pathogenesis of the disease is imbalance of α/β globin chains. The excess of α-globin chains will form hemichromes which can damage red blood cell membranes and lead to hemolysis, ineffective erythropoiesis, and secondary iron overload. Iron overload in turn can cause complications such as growth retardation, liver cirrhosis, cardiac insufficiency, and aggravate the disease phenotype. In recent decades, genes participating in iron metabolism have been discovered, and the mechanism of iron metabolism in the development of thalassemia has gradually been elucidated. Subsequently, by manipulating the expression of key genes in iron metabolism such as hepcidin and transferrin receptor, researchers have revealed that iron restriction can improve ineffective hematopoiesis and iron overload, which may provide a potential approach for the treatment of thalassemia. This article reviews the progress of research on iron metabolism-related genes and related pathways in β-thalassemia.
Humans
;
Iron/metabolism*
;
Iron Overload/genetics*
;
Phenotype
;
Research/trends*
;
beta-Thalassemia/physiopathology*
5.Research progress in the relationship between FOXM1 and neoplasm metabolism
Yu LI ; Yifan JIANG ; Rongliang TONG ; Diyu CHEN ; Jian WU
Journal of Shanghai Jiaotong University(Medical Science) 2024;44(10):1323-1329
FOXM1(forkhead box M1)is an important member of the FOX transcription factor family and plays a critical role in driving the progression of multiple malignancies through its transcriptional regulatory functions.Moreover,the overexpression of FOXM1 is associated with poor prognosis in many types of cancer,as it regulates a variety of biological processes such as gene expression,cell proliferation,invasion,metastasis,and apoptosis.Presently,aberrant metabolic reprogramming has been considered as the major characteristic of cancer development,determining the survival,growth,and proliferation of tumor cells.Accumulating evidence suggests that FOXM1 serves as a"bridge"between metabolism and tumorigenesis.This review aims to provide a comprehensive summary of the research progress in the relationship between FOXM1 and tumor cell metabolism,offering theoretical insights for the development of novel anti-cancer drugs targeting FOXM1.